Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Chiaverini

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nanomedicine (London, England)|April 30, 2025
Liquid chromatography-based metallomics and transmission electron microscopy reveal gold nanoparticle surface treatment with vicinal dithiols to abolish protein corona formationNegar Pourzadi, Lorenzo Chiaverini, Magdalene Patricia Gieschen, et al.
Journal of Inorganic Biochemistry|April 26, 2024
Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a better understanding of its medicinal propertiesLorenzo Chiaverini, Iogann Tolbatov, Alessandro Marrone, et al.
Metallomics : Integrated Biometal Science|November 20, 2025
Solution stability and storage effect on selected metallodrugs: a multi-technique evaluationLuca Famlonga, Riccardo Di Leo, Lorenzo Chiaverini, et al.
Dalton Transactions (Cambridge, England : 2003)|June 20, 2023
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activityGiarita Ferraro, Vanessa Sanfilippo, Lorenzo Chiaverini, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|November 6, 2023
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overviewEmma Baglini, Lorenzo Chiaverini, Iogann Tolbatov, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 8, 2022
Inorganic Drugs as a Tool for Protein Structure Solving and Studies on Conformational ChangesIogann Tolbatov, Alessandro Marrone, William Shepard, et al.
European Journal of Medicinal Chemistry|February 9, 2025
Anticancer activity promoted by ligand diversity in diiron thiocarbyne complexesEkatarina Mihajlović, Lorenzo Biancalana, Marija Mojić, et al.
Inorganic Chemistry|July 8, 2026
Tuning Au Reactivity Beyond Canonical Targets: Ligand-Driven Au(I) Metalation of Lysine Residues in Hen Egg White LysozymeDavide Piroddu, Luca Famlonga, Iogann Tolbatov, et al.
International Journal of Molecular Sciences|July 27, 2022
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced AnaloguesLorenzo Chiaverini, Damiano Cirri, Iogann Tolbatov, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical InvestigationLorenzo Chiaverini, Alessandro Pratesi, Damiano Cirri, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nanomedicine (London, England)|April 30, 2025
Liquid chromatography-based metallomics and transmission electron microscopy reveal gold nanoparticle surface treatment with vicinal dithiols to abolish protein corona formationNegar Pourzadi, Lorenzo Chiaverini, Magdalene Patricia Gieschen, et al.
Journal of Inorganic Biochemistry|April 26, 2024
Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a better understanding of its medicinal propertiesLorenzo Chiaverini, Iogann Tolbatov, Alessandro Marrone, et al.
Metallomics : Integrated Biometal Science|November 20, 2025
Solution stability and storage effect on selected metallodrugs: a multi-technique evaluationLuca Famlonga, Riccardo Di Leo, Lorenzo Chiaverini, et al.
Dalton Transactions (Cambridge, England : 2003)|June 20, 2023
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activityGiarita Ferraro, Vanessa Sanfilippo, Lorenzo Chiaverini, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|November 6, 2023
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overviewEmma Baglini, Lorenzo Chiaverini, Iogann Tolbatov, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 8, 2022
Inorganic Drugs as a Tool for Protein Structure Solving and Studies on Conformational ChangesIogann Tolbatov, Alessandro Marrone, William Shepard, et al.
European Journal of Medicinal Chemistry|February 9, 2025
Anticancer activity promoted by ligand diversity in diiron thiocarbyne complexesEkatarina Mihajlović, Lorenzo Biancalana, Marija Mojić, et al.
Inorganic Chemistry|July 8, 2026
Tuning Au Reactivity Beyond Canonical Targets: Ligand-Driven Au(I) Metalation of Lysine Residues in Hen Egg White LysozymeDavide Piroddu, Luca Famlonga, Iogann Tolbatov, et al.
International Journal of Molecular Sciences|July 27, 2022
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced AnaloguesLorenzo Chiaverini, Damiano Cirri, Iogann Tolbatov, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical InvestigationLorenzo Chiaverini, Alessandro Pratesi, Damiano Cirri, et al.
Pageof 2